Your browser doesn't support javascript.
loading
Sub-myeloablative Second Transplantations with Haploidentical Donors and Post-Transplant Cyclophosphamide have limited Anti-Leukemic Effects in Pediatric Patients.
Epperly, Rebecca; Talleur, Aimee C; Li, Ying; Schell, Sarah; Tuggle, MaCal; Métais, Jean-Yves; Huang, Sujuan; Pei, Deqing; Cheng, Cheng; Madden, Renee; Mamcarz, Ewelina; Naik, Swati; Qudeimat, Amr; Sharma, Akshay; Srinivasan, Ashok; Suliman, Ali; Gottschalk, Stephen; Triplett, Brandon M.
Affiliation
  • Epperly R; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Talleur AC; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Li Y; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Schell S; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Tuggle M; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Métais JY; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Huang S; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Pei D; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Cheng C; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Madden R; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Mamcarz E; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Naik S; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Qudeimat A; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Sharma A; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Srinivasan A; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Suliman A; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Gottschalk S; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Triplett BM; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee. Electronic address: brandon.triplett@stjude.org.
Transplant Cell Ther ; 28(5): 262.e1-262.e10, 2022 05.
Article in En | MEDLINE | ID: mdl-35151936

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / Hematologic Neoplasms Type of study: Clinical_trials / Guideline Limits: Child / Humans Language: En Journal: Transplant Cell Ther Year: 2022 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / Hematologic Neoplasms Type of study: Clinical_trials / Guideline Limits: Child / Humans Language: En Journal: Transplant Cell Ther Year: 2022 Document type: Article Country of publication: